Literature DB >> 33127429

An ecological evaluation of the increasing incidence of endometrial cancer and the obesity epidemic.

Stacy A Smrz1, Corinne Calo2, James L Fisher3, Ritu Salani4.   

Abstract

BACKGROUND: The prevalence of obesity has increased significantly in recent decades, particularly among younger women, and is a known risk factor for endometrial cancer.
OBJECTIVE: This study aimed to evaluate the trend in the prevalence of obesity and the incidence of type I endometrial cancer over time in various age categories to determine whether an ecological relationship exists. STUDY
DESIGN: Data from the Surveillance, Epidemiology, and End Results Program and the National Health and Nutrition Examination Survey were used. The overall trend in the incidence of type 1 endometrial cancer and prevalence of obesity were observed over time from 1988 to 2016 and further categorized by age group (<45, 45-54, and ≥55 years).
RESULTS: The prevalence of obesity has increased for all women, but most significantly for women younger than 45 years with a 16.3% increase among women aged 20 to 34 years and a 17.9% increase for women aged 35 to 44 years. The incidence of endometrial cancer has also increased across all age categories, and although it has increased in patients younger than 45 years by more than 14-fold (from <0.1 per 100,000 in 1988 to 1.4 per 100,000 in 2016), a more pronounced increase of 63-fold and 50-fold was observed among women aged 45 to 54 years (0.2 per 100,000 in 1988 to 12.6 per 100,000 in 2016) and women aged 55 years and older (from 0.6 per 100,000 in 1988 to 30 per 100,000 in 2016), respectively. The mean age of women diagnosed as having endometrial cancer also decreased from 64.1 years from 1988 to 1990 to 61.0 years from 2014 to 2016.
CONCLUSION: The prevalence of obesity has increased significantly in women of all ages. This increase, particularly among women aged <45 years, occurred simultaneously with an increase in the incidence of endometrial cancer in young women, with an even more pronounced increase among women aged ≥45 years. Published by Elsevier Inc.

Entities:  

Keywords:  Epidemiology; Surveillance; and End Results Program; endometrial cancer; obesity

Mesh:

Year:  2020        PMID: 33127429     DOI: 10.1016/j.ajog.2020.10.042

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.

Authors:  Jiali Leng; Fei Wu; Lihui Zhang
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

2.  KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.

Authors:  Meghan L Rudd; Nancy F Hansen; Xiaolu Zhang; Mary Ellen Urick; Suiyuan Zhang; Maria J Merino; James C Mullikin; Lawrence C Brody; Daphne W Bell
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

3.  Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer.

Authors:  Michiko Wada; Ken Yamaguchi; Hajime Yamakage; Takayuki Inoue; Toru Kusakabe; Kaoru Abiko; Kenji Takakura; Ikuo Konishi; Noriko Satoh-Asahara
Journal:  Int J Clin Oncol       Date:  2021-10-30       Impact factor: 3.402

4.  A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer.

Authors:  Diocésio Alves Pinto de Andrade; Luciane Sussuchi da Silva; Ana Carolina Laus; Marcos Alves de Lima; Gustavo Nóriz Berardinelli; Vinicius Duval da Silva; Graziela de Macedo Matsushita; Murilo Bonatelli; Aline Larissa Virginio da Silva; Adriane Feijó Evangelista; Jesus Paula Carvalho; Rui Manuel Reis; Ricardo Dos Reis
Journal:  Front Oncol       Date:  2021-08-17       Impact factor: 6.244

5.  Molecular classification grade 3 endometrial endometrioid carcinoma using a next-generation sequencing-based gene panel.

Authors:  Ling Li; Fangfang Chen; Jingcheng Liu; Weifeng Zhu; Liang Lin; Li Chen; Yi Shi; An Lin; Gang Chen
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

6.  Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study.

Authors:  Kuo-Chang Wen; Rui-Lan Huang; Lin-Yu Chen; Tzu-I Wu; Chien-Hsing Lu; Tang-Yuan Chu; Yu-Che Ou; Chen-Hsuan Wu; Shih-Tien Hsu; Dah-Ching Ding; Ling-Hui Chu; Chien-Wen Chen; Heng-Cheng Chang; Yu-Shu Liu; Hui-Chen Wang; Yu-Chun Weng; Po-Hsuan Su; Hao Lin; Hung-Cheng Lai
Journal:  Cancers (Basel)       Date:  2022-09-05       Impact factor: 6.575

Review 7.  Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context.

Authors:  Emily Paterson; Cherie Blenkiron; Kirsty Danielson; Claire Henry
Journal:  Transl Oncol       Date:  2022-07-09       Impact factor: 4.803

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.